Despite representing a large proportion of the general population with a high disease burden, racial and ethnic minority populations have been consistently underrepresented in clinical trials. Dr. Elizabeth Ofili, professor of medicine at Morehouse School of Medicine and a practicing cardiologist with Morehouse Healthcare in Atlanta has information about a collaboration between Amgen, the Association of Black Cardiologists (ABC) and the Morehouse School of Medicine.